US 11007183
Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors
granted A61KA61K31/4439A61K31/506
Quick answer
US patent 11007183 (Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors) held by Biomed Valley Discoveries, Inc. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4439, A61K31/506, A61K31/5377, A61K45/06